|
|
Article: FDA to review New Drug Application for Oracea.(PIPELINE PREVIEWS)
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- January 1, 2006
CopyrightCOPYRIGHT 2006 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CollaGenex Pharmaceuticals, Inc., announced that the FDA has accepted to review its New Drug Application for Oracea, an oral tetracycline medication developed to treat rosacea. The New Drug Application data was primarily based on two Phase 3 double-blinded placebo-controlled trials that demonstrated a 61% ...